Active, not recruitingPhase 2NCT03856658

Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases

Studying Pediatric hepatocellular carcinoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Corewell Health West
Principal Investigator
G. Paul Wright, MD, MD
Corewell Health
Intervention
Floxuridine (FUDR)(drug)
Enrollment
14 enrolled
Eligibility
18-75 years · All sexes
Timeline
20192025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03856658 on ClinicalTrials.gov

Other trials for Pediatric hepatocellular carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Pediatric hepatocellular carcinoma

← Back to all trials